David Fogel, Cpa

About Our Group Founded 2/2006, Beacon Angels, a Boston-based angel group, celebrated a significant exit in the sale of SmartCells to Merck in December 2010. Members conduct due diligence and invest in early stage companies that demonstrate (1) strong third party buy-in, (2) protected technology and (3) a clear exit strategy. Submit executive summaries through www.beaconangels.com. Referred plans only please. Beacon Angels is a Boston-based angel group that makes investments in the $100,000 to $300,000 range in small fast-growing companies. Membership Beacon Angels members attract and access a steady flow of early-stage private investment opportunities, and build portfolio value through shared capital, experience, and strategic relationships. Please see www.beaconangels.com to learn about joining. Meetings We meet on the second Tuesday of each month, often at the offices of Swiggart & Agin, LLC, and occasionally at the Union Club of Boston, to review and discuss presentations from companies. Accredited investors may attend as guests of members. Guest Fee: $45.

Beacon Angels is a Boston-based angel group that invests in the $50,000 to $400,000 range in early-stage, fast-growing companies. Since our 2006 founding, Beacon has helped grow many successful New England-based startup companies.

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community. Our focus is on early stage life science companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, we can fund all or a portion of the round, and will work closely with other angel groups or venture funds in the area to complete the round. We are looking for companies that are extremely capital efficient opportunities where our funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds.

Whether you are looking for insights on emerging technology or for one-on-one mentoring, TiE Boston offers you the resources and content you need to develop your next opportunity into reality. TiE Boston is a comprehensive eco-system for entrepreneurs with the mission to foster, encourage, and support entrepreneurship in the New England region. We connect entrepreneurs with each other and stakeholders in the entrepreneurial world including serial entrepreneurs, Angel Investors, Venture Capitalists, Vendors and Service Providers. We run several vibrant programs to educate, mentor, network, and inspire entrepreneurs in the community. These programs are the forum where talent, ideas, and enterprise mingle in a potent combination to generate innovation. While our programs have facilitated the growth of companies worth billions of dollars in net worth, the business leaders attending these programs still retain the camaraderie that sparked the formation of TiE-Boston 15 years ago. TiE Boston is based in Cambridge, MA and is part of the Global TiE (The Indus Entrepreneurs) group, the largest not-for-profit organization promoting entrepreneurship, which has over 12,000 members in 62 chapters worldwide.

The Angel Capital Association (ACA) is the professional society of angel groups and private investors that invest in high growth, early-stage ventures. Our mission is to fuel the success of angel groups and private investors that invest in high growth, early-stage ventures. ACA provides professional development and delivers services and benefits to support the success of ACA members. We also serve as the promotional voice for the global angel community and the public policy voice for the US professional angel community. ACA membership includes more than 250 angel groups, accredited platforms and family offices from across the world. Our members represent more than 8,000 accredited investors funding approximately 5,000 portfolio companies.

About Our Group Founded 2/2006, Beacon Angels, a Boston-based angel group, celebrated a significant exit in the sale of SmartCells to Merck in December 2010. Members conduct due diligence and invest in early stage companies that demonstrate (1) strong third party buy-in, (2) protected technology and (3) a clear exit strategy. Submit executive summaries through www.beaconangels.com. Referred plans only please. Beacon Angels is a Boston-based angel group that makes investments in the $100,000 to $300,000 range in small fast-growing companies. Membership Beacon Angels members attract and access a steady flow of early-stage private investment opportunities, and build portfolio value through shared capital, experience, and strategic relationships. Please see www.beaconangels.com to learn about joining. Meetings We meet on the second Tuesday of each month, often at the offices of Swiggart & Agin, LLC, and occasionally at the Union Club of Boston, to review and discuss presentations from companies. Accredited investors may attend as guests of members. Guest Fee: $45.

Beacon Angels is a Boston-based angel group that invests in the $50,000 to $400,000 range in early-stage, fast-growing companies. Since our 2006 founding, Beacon has helped grow many successful New England-based startup companies.

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Our goal is to provide money and mentoring to the life science community to achieve superior returns for our group, and more clinical innovation for the community. Our focus is on early stage life science companies looking to raise $250K to $3.0M. Depending on the amount of funding needed, we can fund all or a portion of the round, and will work closely with other angel groups or venture funds in the area to complete the round. We are looking for companies that are extremely capital efficient opportunities where our funds will lead to significant step-ups in valuation to avoid unfavorable future funding rounds.